176 related articles for article (PubMed ID: 35589944)
1. Low adherence to the guideline for the acute treatment of migraine.
Olesen A; Schytz HW; Ostrowski SR; Topholm M; Nielsen K; Erikstrup C; Mikkelsen S; Pedersen OB; Olesen J; Hansen TF; Chalmer MA
Sci Rep; 2022 May; 12(1):8487. PubMed ID: 35589944
[TBL] [Abstract][Full Text] [Related]
2. Twenty-five years of triptans - a nationwide population study.
Davidsson OB; Olofsson IA; Kogelman LJ; Andersen MA; Rostgaard K; Hjalgrim H; Olesen J; Hansen TF
Cephalalgia; 2021 Jul; 41(8):894-904. PubMed ID: 33583217
[TBL] [Abstract][Full Text] [Related]
3. A global real-world assessment of the impact on health-related quality of life and work productivity of migraine in patients with insufficient versus good response to triptan medication.
Lombard L; Farrar M; Ye W; Kim Y; Cotton S; Buchanan AS; Jackson J; Joshi S
J Headache Pain; 2020 Apr; 21(1):41. PubMed ID: 32349662
[TBL] [Abstract][Full Text] [Related]
4. Comparison of healthcare resource utilization and costs among patients with migraine with potentially adequate and insufficient triptan response.
Marcus SC; Shewale AR; Silberstein SD; Lipton RB; Young WB; Viswanathan HN; Doshi JA
Cephalalgia; 2020 Jun; 40(7):639-649. PubMed ID: 32223301
[TBL] [Abstract][Full Text] [Related]
5. Lasmiditan efficacy in the acute treatment of migraine was independent of prior response to triptans: Findings from the CENTURION study.
Reuter U; Krege JH; Lombard L; Gomez Valderas E; Krikke-Workel J; Dell-Agnello G; Dowsett SA; Buse DC
Cephalalgia; 2022 Jan; 42(1):20-30. PubMed ID: 34644189
[TBL] [Abstract][Full Text] [Related]
6. Impact of NSAID and Triptan use on developing chronic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study.
Lipton RB; Serrano D; Nicholson RA; Buse DC; Runken MC; Reed ML
Headache; 2013; 53(10):1548-63. PubMed ID: 23992516
[TBL] [Abstract][Full Text] [Related]
7. European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure.
Sacco S; Lampl C; Amin FM; Braschinsky M; Deligianni C; Uludüz D; Versijpt J; Ducros A; Gil-Gouveia R; Katsarava Z; Martelletti P; Ornello R; Raffaelli B; Boucherie DM; Pozo-Rosich P; Sanchez-Del-Rio M; Sinclair A; Maassen van den Brink A; Reuter U
J Headache Pain; 2022 Oct; 23(1):133. PubMed ID: 36224519
[TBL] [Abstract][Full Text] [Related]
8. Triptans for Acute Migraine Headache: Current Experience With Triptan Use and Prescription Habits in a Tertiary Care Headache Outpatient Clinic: An Observational Study.
Fischer M; Frank F; Wille G; Klien S; Lackner P; Broessner G
Headache; 2016 Jun; 56(6):952-60. PubMed ID: 27091593
[TBL] [Abstract][Full Text] [Related]
9. Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis.
Cameron C; Kelly S; Hsieh SC; Murphy M; Chen L; Kotb A; Peterson J; Coyle D; Skidmore B; Gomes T; Clifford T; Wells G
Headache; 2015; 55 Suppl 4():221-35. PubMed ID: 26178694
[TBL] [Abstract][Full Text] [Related]
10. Perinatal use of triptans and other drugs for migraine-A nationwide drug utilization study.
Tauqeer F; Wood M; Hjorth S; Lupattelli A; Nordeng H
PLoS One; 2021; 16(8):e0256214. PubMed ID: 34424941
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of rimegepant for the acute treatment of migraine based on triptan treatment experience: Pooled results from three phase 3 randomized clinical trials.
Lipton RB; Blumenfeld A; Jensen CM; Croop R; Thiry A; L'Italien G; Morris BA; Coric V; Goadsby PJ
Cephalalgia; 2023 Feb; 43(2):3331024221141686. PubMed ID: 36739511
[TBL] [Abstract][Full Text] [Related]
12. Triptans and vascular comorbidity in persons over fifty: Findings from a nationwide insurance database - A cohort study.
Zebenholzer K; Gall W; Gleiss A; Pavelic AR; Wöber C
Headache; 2022 May; 62(5):604-612. PubMed ID: 35593784
[TBL] [Abstract][Full Text] [Related]
13. Risk of Stroke and Myocardial Infarction Among Initiators of Triptans.
Petersen CL; Hougaard A; Gaist D; Hallas J
JAMA Neurol; 2024 Mar; 81(3):248-254. PubMed ID: 38315477
[TBL] [Abstract][Full Text] [Related]
14. Potential Channeling Bias in the Evaluation of Cardiovascular Risk: The Importance of Comparator Selection in Observational Research.
Li H; Mawanda F; Mitchell L; Zhang X; Goodloe R; Vincent M; Motsko S
Pharmaceut Med; 2022 Aug; 36(4):247-259. PubMed ID: 35788962
[TBL] [Abstract][Full Text] [Related]
15. Triptans and migraine: advances in use, administration, formulation, and development.
Macone AE; Perloff MD
Expert Opin Pharmacother; 2017 Mar; 18(4):387-397. PubMed ID: 28129702
[TBL] [Abstract][Full Text] [Related]
16. Post Hoc Subanalysis of Two Randomized, Controlled Phase 3 Trials Evaluating Diclofenac Potassium for Oral Solution: Impact of Migraine-Associated Nausea and Prior Triptan Use on Efficacy.
Lipton RB; Schmidt P; Diener HC
Headache; 2017 May; 57(5):756-765. PubMed ID: 28386945
[TBL] [Abstract][Full Text] [Related]
17. Identifying the factors underlying discontinuation of triptans.
Wells RE; Markowitz SY; Baron EP; Hentz JG; Kalidas K; Mathew PG; Halker R; Dodick DW; Schwedt TJ
Headache; 2014 Feb; 54(2):278-89. PubMed ID: 24001117
[TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness of Reclassifying Triptans in Australia: Application of an Economic Evaluation Approach to Regulatory Decisions.
Parkinson B; Gumbie M; Cutler H; Gauld N; Mumford V; Haywood P
Value Health; 2019 Mar; 22(3):293-302. PubMed ID: 30832967
[TBL] [Abstract][Full Text] [Related]
19. Education and decision making at the time of triptan prescribing: patient expectations vs actual practice.
Mathew PG; Pavlovic JM; Lettich A; Wells RE; Robertson CE; Mullin K; Charleston Iv L; Dodick DW; Schwedt TJ
Headache; 2014 Apr; 54(4):698-708. PubMed ID: 24512184
[TBL] [Abstract][Full Text] [Related]
20. Triptan education and improving knowledge for optimal migraine treatment: an observational study.
Baron EP; Markowitz SY; Lettich A; Hastriter E; Lovell B; Kalidas K; Dodick DW; Schwedt TJ;
Headache; 2014 Apr; 54(4):686-97. PubMed ID: 24520930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
